IQVIA announced that AstraZeneca has selected IQVIA Technologies’s Orchestrated Customer Engagement (OCE) platform to further its digital agenda and establish its 'Field of the Future'. AstraZeneca (AZ) selected OCE for initial rollout within the U.S. to support its focus on Oncology and specialized medicines. OCE offers functionality for better customer engagement, decision making and collaboration for multiple field users who call on the same complex accounts. Using best-in-class technology, including machine learning algorithms and advanced analytics, OCE enhances customer insights and improves decision making. OCE allows users in customer-facing roles to share a consistent and continuously updated view of all interactions with large, complex accounts to optimize each engagement. This functionality helps unify and coordinate AstraZeneca sales, in-house marketing and medical functions by reducing operational and information silos. AstraZeneca joins more than 80 other biopharmaceutical customers that selected IQVIA OCE’s innovative solutions to address the market momentum and need for innovative platforms to advance customer engagement.